Evidence map›Paper›PMID 39138814›Full record

ReviewCurrent urology reports2024

Results of Radical Nephrectomy and Inferior Vena Cava Thrombectomy.

Roberto Filizzola, Daniel Romero, Samuel Mendez, David Brunstein, Alejandro Benitez

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roberto FilizzolaDepartment of Vascular Surgery, Hospital Central Instituto de Prevision Social, Asunción, 001519, Paraguay. renfa9801@icloud.com.
Daniel RomeroDepartment of Urology, Hospital Central Instituto de Previsión Social, Asunción, 001519, Paraguay.
Samuel MendezDepartment of Urology, Hospital Central Instituto de Previsión Social, Asunción, 001519, Paraguay.
David BrunsteinDepartment of Vascular Surgery, Hospital Central Instituto de Prevision Social, Asunción, 001519, Paraguay.
Alejandro BenitezDepartment of Vascular Surgery, Hospital Central Instituto de Prevision Social, Asunción, 001519, Paraguay.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewRenal Cell Carcinoma (RCC) with invasion into the inferior vena cava (IVC) is a rare and mortal condition. Patients with RCC have an average life expectancy of no more than six months, thus requiring an aggressive surgical approach. We analyze the outcomes of patients that underwent surgery at a single medical institution. RECENT

findingsThe analysis of recent series of successful treatment with radical nephrectomy and IVC thrombectomy shows a 5 year survival from 45 to 69%. We found in the analyzed series that the success of the treatment in these patients depends on the resection of the renal tumor and venous thrombectomy. We found that at our medical institution nephrectomy and IVC thrombectomy with primary repair have no intraoperative mortality and no pulmonary embolism. Nephrectomy and thrombectomy of IVC is a reliable approach for patients with advance RCC.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsNephrectomyThrombectomyVena Cava, InferiorHumansNeoplasm InvasivenessTreatment OutcomeInferior vena cavaRenal cell carcinomaVena cava thrombectomy

Identifiers

PMID39138814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.